ClinicalTrials.gg
CompletedNCT02494271Updated Jul 13, 2015

TIVA, Inhalation Anesthesia, and Surgical Site Infection

An observational study in Colorectal Disorders, sponsored by Seoul National University Bundang Hospital. Completed at 1 site in South Korea. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2015-07-13.

Sponsored by Seoul National University Bundang Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
2,046
Ages
20 Years to 90 Years
Sex
All
01

Study summary

The purpose of this retrospective study was to evaluate the incidence of SSI after colorectal surgery under the general anesthesia by different general anesthetic technique: inhalation versus total intravenous anesthesia.

02

Conditions studied

  • Colorectal Disorders
03

In context

Lead sponsor

Seoul National University Bundang Hospital is the lead sponsor of 376 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients who underwent elective colorectal surgery under general anesthesia from January 2011 to December 2013 at SNUBH.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients who underwent elective colorectal surgery under general anesthesia from January 2011 to December 2013.

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
2,046 participants (actual)
Patient registry
No

Groups and cohorts

  • Total intravenous anesthesia

    Total intravenous anesthesia using propofol and remifentanil

  • Inhalation

    Balanced inhalation anesthesia using volatile anesthetics and remifentanil

06

What researchers measure

Primary outcomes

  1. Surgical site infection

    Number of participants with surgical site infection

    Time frame: Postoperative 30 day

Secondary outcomes

  1. Postoperative C-reactive protein

    Plasma concentration

    Time frame: Postoperative 1 day

  2. Segmented neutrophil count

    Segmented neutrophil count

    Time frame: Preoperaitve 1 day, postoperative 1 day

  3. Transfusion

    Number of unit of transfused red blood cells

    Time frame: The day of operation, postoperative 30 day

07

Study locations

1 site
  • Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do 463-707, South Korea
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02494271
Responsible party
Hyo-Seok Na (Dr, Seoul National University Bundang Hospital) — Principal investigator
First posted
Jul 10, 2015
Start date
Jan 2015
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Jul 13, 2015
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion